Anti-inflammatory treatments for chronic diseases: a review

D Laveti, M Kumar, R Hemalatha… - … & Allergy-Drug …, 2013 - ingentaconnect.com
Inflammation is viewed as one of the major causes for the development of different diseases
like cancer, cardiovascular disease, diabetes, obesity, osteoporosis, rheumatoid arthritis …

Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility

PG Baraldi, MA Tabrizi, S Gessi, PA Borea - Chemical reviews, 2008 - ACS Publications
The purine nucleoside adenosine is consensually identified as a major local regulator of
tissue function especially when energy supply fails to meet cellular energy demand. Due to …

Treatment effects of low-dose theophylline combined with an inhaled corticosteroid in COPD

PA Ford, AL Durham, REK Russell, F Gordon… - Chest, 2010 - Elsevier
Background Inhaled corticosteroids (ICS) have proved disappointing at reducing airway
inflammation in COPD. However, previous studies indicate that low doses of theophylline …

Theophylline: Old drug in a new light, application in COVID-19 through computational studies

LM Montaño, B Sommer, JC Gomez-Verjan… - International Journal of …, 2022 - mdpi.com
Theophylline (3-methyxanthine) is a historically prominent drug used to treat respiratory
diseases, alone or in combination with other drugs. The rapid onset of the COVID-19 …

Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD

MA Giembycz, SK Field - Drug design, development and therapy, 2010 - Taylor & Francis
In April 2010, the European Medicines Agency Committee for Medicinal Products for Human
Use recommended approval of roflumilast, a selective phosphodiesterase 4 inhibitor, for the …

Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD

BG Cosio, A Iglesias, A Rios, A Noguera, E Sala, K Ito… - Thorax, 2009 - thorax.bmj.com
Background: Chronic obstructive pulmonary disease (COPD) is characterised by an
abnormal inflammatory response mainly to cigarette smoke that flares up during …

Theophylline for the management of respiratory disorders in adults in the 21st century: A scoping review from the American College of Clinical Pharmacy Pulmonary …

PM Boylan, M Abdalla, B Bissell… - … : The Journal of …, 2023 - Wiley Online Library
Theophylline is an oral methylxanthine bronchodilator recommended as alternate therapy
for the treatment of asthma and chronic obstructive pulmonary disease (COPD). However, it …

Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis

JL Simpson, S Phipps, PG Gibson - Pharmacology & therapeutics, 2009 - Elsevier
Obstructive airway diseases such as asthma and chronic obstructive pulmonary disease
(COPD) are major global health issues. Although considered as distinct diseases, airway …

Sputum myeloperoxidase in chronic obstructive pulmonary disease

A Zhu, D Ge, J Zhang, Y Teng, C Yuan… - European journal of …, 2014 - Springer
Background Airway inflammation, especially neutrophilic airway inflammation, is a cardinal
pathophysiologic feature in chronic obstructive pulmonary disease (COPD) patients. The …

[PDF][PDF] Alkaloids and athlete immune function: caffeine, theophylline, gingerol, ephedrine, and their congeners.

DS Senchina, JE Hallam, ML Kohut… - Exercise immunology …, 2014 - researchgate.net
Plant alkaloids are found in foods, beverages, and supplements consumed by athletes for
daily nutrition, performance enhancement, and immune function improvement. This paper …